Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

0 of 9 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

4(44.4%)

Phase 1

2(22.2%)

Phase 2

2(22.2%)

Phase 3

1(11.1%)

9Total

N/A(4)

Phase 1(2)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT04870203Phase 3Active Not Recruiting

Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis

Role: collaborator

NCT04800458Not ApplicableRecruiting

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Role: collaborator

NCT04196868Phase 2Active Not Recruiting

Methotrexate and Metformin in Rheumatoid Arthritis Patients

Role: collaborator

NCT05098704Phase 2Recruiting

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

Role: collaborator

NCT04005638Recruiting

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

Role: collaborator

NCT04881032Phase 1Active Not Recruiting

AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma

Role: collaborator

NCT02898090Completed

Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions

Role: collaborator

NCT02850809Completed

Evaluation of the Efficacy of Radiofrequency in the Treatment of Renal Tumors

Role: collaborator

NCT03722212Not ApplicableCompleted

Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test

Role: collaborator

NCT02280902Completed

Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases

Role: collaborator

NCT02264899Not ApplicableCompleted

MEMENTO-VAScular COmponents of Dementia

Role: collaborator

NCT02417272Not ApplicableCompleted

Total Disc Replacement Versus Anterior Cervical Decompression and Fusion

Role: collaborator

NCT02320357Phase 1Completed

Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous

Role: collaborator

NCT02334930Completed

Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors